Reviewer #2 (Public review):  
Summary  
The authors demonstrate heightened susceptibility of Terc-KO mice to S. aureus-induced pneumonia, perform gene expression analysis from the infected lungs, find an elevated inflammatory (NLRP3) signature in some Terc-KO but not control mice, and some reduction in T cell signatures. Based on that, they conclude that dysregulated inflammation and T cell dysfunction play a major role in these phenomena.  
The strengths of the work did not change, and include a problem not previously addressed (the role of Terc component of the telomerase complex) in certain aspects of resistance to bacterial infection and innate (and maybe adaptive) immune function.<br />
The weaknesses of this revised version still outweigh the strengths, because the authors did not substantially or experimentally answer the main criticism points, and have rather tried to argue away that which cannot be argued away. In summary, the most germane conclusions of this study remain plagued by flaws in experimental design, by lack of rigorous controls and by incomplete and inadequate approaches to testing of immune function.  
I will devote the rest of the comments to the revised manuscript and its success or lack thereof in responding to prior criticisms. Prior criticisms are again listed below in italics, to provide context for the attempts of the investigators to respond.  
(1) Reviewer 1 has justifiably criticized the exceptionally low power of the study, with 5 control and 3 experimental animals. The responding author has replied that the animal welfare laws preclude them from doing more experiments. That is unfortunate, and I sympathize with the authors. Nonetheless, in the absence of robust corroboration the rigor of the study remains severely compromised and the work is reduced to what I have pointed above - a preliminary and inconclusive study that is in need of deeper and more serious mechanistic investigation.  
(2) Terc-KO mice are a genomic knockout model, and therefore the authors need to carefully consider the impact of this KO on a wide range of tissues. This, however, is not the case. There are no attempts to perform cell transfers, use irradiation chimera or crosses that would be informative.  
In response to this criticism, the authors have quoted a whole bunch of papers characterizing different aspects of biology of these same mice. The most important paper in that regard would be the one by Matthe et al. on CD4 cells from these same mice. That study was limited and simply diagnosed in situ the changes in T cell pool, but did not decipher whether and to what extent such defects are cell-intrinsic or a byproduct of similarly altered microenvironments. Most importantly, none of that answers the original critique question of which cell types are truly the culprits in the Terc deletion phenotype presented here. As I indicated, one has to perform cell transfers, bone marrow irradiation chimera, additional genetic crosses and combinations thereof to substantiate whether the defects are ascribable to the lung tissue itself, the infiltrating myeloid cells, including macrophages, the T cells or a combination thereof. The authors provided none of this.  
(3) Throughout the manuscript the authors invoke the role of telomere shortening in aging, and according to them their Terc-KO mice should be one potential model for aging. Yet the authors consistently describe major differences between young Terc-KO and naturally aging old mice, with no discussion of the implications. This further confuses the biological significance of this work as presented.  
(4) Related to #2, group design for comparisons lacks a clear rationale. The authors stipulate that Terc-KO will mimic natural aging, but in fact, the only significant differences seen between groups in susceptibility to S. aureus are, contrary to the authors' expectation, between young Terc-KO and naturally old mice (Fig. 1A and B, no difference between young Terc-KO and young wt); or there are no significant differences at all between groups (Fig. 1, C, D,). I have also raised the issue of non-physiological nature of a germline Terc-KO, that does not mimic any known physiological or pathological state.<br />
The authors provided a non-response to this criticism. They argue in their response under (2) of their rebuttal that they included old mice as controls not for aging, because their experimental Terc-deletion mice were G3 and do not exhibit as much of a progeroid phenotype as G5 or G6 mice. But they still say in the revised formulation that these mice were infected "to explore the potential link to a fully developed aging phenotype". They just never conclude that no such link is substantiated by the vast majority of their data. Moreover, they come back to state in their response (4) that because the literature reported ".... reduction of Terc and Tert in tissues of old mice and rats. Therefore, as a potential immunomodulatory factor reduced Terc expression could be connected to age-related pathologies." So either they have used old mice here to compare aging phenotypes, and found that Terc-KO mice diverge massively from aging phenotypes, in which case they have to state so, or they are not using them as age comparators (in which case I am not sure what their purpose is).  
(5) (originally part of criticism #4) I have criticized inadequate group design is when the authors begin dividing their Terc-KO groups by clinical score into animals with or without "systemic infection" (the condition where a bacterium spreads uncontrollably across the many organs and via blood, which should be properly called sepsis), and then compare this sepsis group to other groups (Suppl Fig. 1G; Fig. 2; lines 374-376 and 389-391). .... Most importantly, methodologically it is highly inappropriate to compare one mouse with sepsis to another one without. If Terc-KO mice with sepsis are a comparator group, then their controls have to be wild type mice with sepsis, who are dealing with the same high bacterial load across the body and are presumably forced to deploy the same set of immune defenses.<br />
The authors responded by making me aware of the 2016 JAMA definition of sepsis that invokes "a life-threatening organ dysfunction caused by a dysregulated host response to infection". I appreciate the correction, and note that in a human setting and globally, such a definition may make sense. The authors stated that bacteremia and not sepsis should be used as a criterion. I agree, and per my original criticism, believe it will be appropriate to compare bacteremic wt and KO mice.  
(6) I am shortening my prior critique to make it more to the point that was not addressed: The authors conclude that disregulated inflammation and T cell dysfunction play a major role in S. aureus susceptibility. This may or may not be an important observation, because many KO mice are abnormal for a variety of reasons, and until such reasons are mechanistically dissected, the physiological importance of the observation will remain unclear. ....., the authors truly did not examine the key basic features of their model, including the features of basic and induced inflammatory and immune response. This analysis could be done either using model antigens in adjuvants, defined innate immune stimuli (e.g. TLR, RLR or NLR agonsists), or microbial challenge. The only data provided along these lines are the baseline frequencies of total T cells in the spleen of the three groups of mice examined (not statistically significant, Fig. 4B). We do not know if the composition of naïve to memory T cell subsets may have been different, and more importantly, we have no data to evaluate whether recruitment of the immune response (including T cells) to the lung upon microbial challenge is similar or different. So, what are the numbers and percentages of T cells and alveolar macrophages in the lung following S. aureus challenge and are they even comparable or are there issues in mobilizing the T cell response to the site of infection ? If, for example, Terc-KO mice do not mobilize enough T cells to the lung during infection, that would explain paucity in many T cell -associated genes in their transcriptomic set that they authors report. That in turn may not mean dysfunction of T cells but potentially a whole different set of defects in coordinating the response in Terc-KO mice.<br />
The authors did not respond to this criticism other than to provide more frequencies of different subsets. The key here are the NUMBERS of cells present at the peak of challenge, or better yet the kinetics of cell accumulation (again numbers), as well as transfer experiments to establish where the defect actually lies (mobilization, activation, proliferation, etc.).  
(7) Related to that, immunological analysis is also inadequate. First, the authors pull signatures from the total lung tissue, which is both imprecise and potentially skewed by differences not in gene expression but in types of cells present and/or their abundance, a feature known to be affected by aging and perhaps by Terc deficiency during infection. Second, to draw any conclusions about immune responses, the authors would have to track antigen-specific T cells, which is possible for a wide range of microbial pathogens using peptide-MHC multimers. This would allow highly precise analysis of phenomena the authors are trying to conclude about. Moreover, it would allow them to confirm their gene expression data in populations of physiological interest.<br />
The authors agreed that this would be of interest but did nothing to provide it. They provided a sentence in the discussion stating that this (as well as many other experiments needed to interpret the results) would be of interest.  
(8) Overall, the authors begun to address the role of Terc in bacterial susceptibility, but to what extent that specifically involves inflammation and macrophages, T cell immunity or aging remains unclear at the present.<br />
My conclusion from the prior review remains unchanged in the face of the revision that did not answer most of the previous criticism. The study as it stands is inconclusive and highly preliminary, with lack of clearly defined mechanistic underpinnings.